CoChat

Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis

Open access
Gerussi, Alessio, Bernasconi, Davide Paolo, O'Donnell, Sarah Elisabeth, Lammers, Willem J., Van Buuren, Henk, Hirschfield, Gideon, Janssen, Harry, Corpechot, Christophe, Reig, Anna, Pares, Albert, Battezzati, Pier Maria, Zuin, Massimo Giovanni, Cazzagon, Nora, Floreani, Annarosa, Nevens, Frederik, Gatselis, Nikolaos, Dalekos, George, Mayo, Marlyn J., Thorburn, Douglas, Bruns, Tony, Mason, Andrew L., Verhelst, Xavier, Kowdley, Kris, van der Meer, Adriaan, Niro, Grazia Anna, Beretta-Piccoli, Benedetta Terziroli, Marzioni, Marco, Belli, Luca Saverio, Marra, Fabio, Valsecchi, Maria Grazia, Lindor, Keith D., Invernizzi, Pietro, Hansen, Bettina E., Carbone, Marco · 2021 · Clinical Gastroenterology and Hepatology
Cited by 62

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

BACKGROUND AND AIMS Gamma-glutamyltransferase (GGT) is a serum marker of cholestasis. We investigated whether serum level of GGT is a prognostic marker for patients with primary biliary cholangitis (PBC). METHODS We analyzed data from patients with PBC from the Global PBC Study Group, comprising 14 centers in Europe and North America. We obtained measurements of serum GGT at baseline and time points after treatment. We used Cox model hazard ratios to evaluate the association between GGT and clinical outcomes, including liver transplantation and liver-related death. RESULTS Of the 2129 patients included in our analysis, 281 (13%) had a liver-related clinical endpoint. Mean age at diagnosis was 53 years and 91% of patients were female patients. We found a correlation between serum levels of GGT and alkaline phosphatase (ALP) (r=0.71). Based on data collected at baseline and yearly for up to 5 years, higher serum level of GGT were associated with lower hazard for transplant-free survival. Serum level of GGT at 12 months after treatment higher than 3.2-fold the upper limit of normal (ULN) identified patients who required liver transplantation or with liver-related death at 10 years with an area under the receiver operating characteristic curve of 0.70. The risk of liver transplantation or liver-related death in patients with serum level of GGT above 3.2-fold the ULN, despite level of ALP lower than 1.5-fold the ULN, was higher compared to patients with level of GGT lower than 3.2-fold the ULN and level of ALP lower than 1.5-fold the ULN (P<.05). Including information on level of GGT increased the prognostic value of the Globe score. CONCLUSION Serum level of GGT can be used to identify patients with PBC at risk for liver transplantation or death, and increase the prognostic value of ALP measurement. Our findings support the use of GGT as primary clinical endpoint in clinical trials. In patients with low serum level of ALP, a high level of GGT identifies those who might require treatment of metabolic disorders or treatment escalation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cgh.2020.08.006

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 62

Metadata

Authors
Gerussi, A., Bernasconi, D. P., O'Donnell, S. E., Lammers, W. J., Van Buuren, H., Hirschfield, G., Janssen, H., Corpechot, C., Reig, A., Pares, A., Battezzati, P. M., Zuin, M. G., Cazzagon, N., Floreani, A., Nevens, F., Gatselis, N., Dalekos, G., Mayo, M. J., Thorburn, D., Bruns, T., Mason, A. L., Verhelst, X., Kowdley, K., van der Meer, A., Niro, G. A., Beretta-Piccoli, B. T., Marzioni, M., Belli, L. S., Marra, F., Valsecchi, M. G., Lindor, K. D., Invernizzi, P., Hansen, B. E., & Carbone, M.
Venue
Clinical Gastroenterology and Hepatology
Publisher
Elsevier BV
Published
2021-08
Volume
19
Issue
8
Pages
1688-1697.e14
ISSN
1542-3565 (ISSN-L)
OpenAlex
W3048139705
Cited by
62
References
11
FWCI
3.69
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis. https://app.cochat.ai/papers/10.1016/j.cgh.2020.08.006
The paper
Gerussi, A., Bernasconi, D. P., O'Donnell, S. E., Lammers, W. J., Van Buuren, H., Hirschfield, G., Janssen, H., Corpechot, C., Reig, A., Pares, A., Battezzati, P. M., Zuin, M. G., Cazzagon, N., Floreani, A., Nevens, F., Gatselis, N., Dalekos, G., Mayo, M. J., Thorburn, D., . . . Carbone, M. (2021). Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2020.08.006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.